UnitedHealth Rises as Investors Burry and Buffett Back It

Author: Evelyn Baker Updated: 08-15-2025 12:43 AM

UnitedHealth Group Inc. Surges on Major Investment News

UnitedHealth Group Inc. (NYSE: UNH) is attracting attention after experiencing a significant 10.69% increase in after-hours trading due to the involvement of renowned investors, Michael Burry and Warren Buffett. Both financial giants have taken substantial positions in this prominent healthcare firm, underscoring a potential rebound in its fortunes.

Burry's Unexpected Contrarian Investment

Michael Burry, famous for his role in 'The Big Short,' has made headlines by acquiring call contracts on 350,000 shares of UnitedHealth through his hedge fund, Scion Asset Management. This revelation came to light through the Securities and Exchange Commission's 13F filings, showcasing Burry's belief in the healthcare sector's upswing.

Additionally, Burry's firm has invested approximately $6 million in about 20,000 common shares. This move marks a significant shift for Burry, known for his typically bearish outlooks, revealing his confidence in UnitedHealth's potential despite its current trading position near five-year lows.

Buffett's Significant Stake in Healthcare

Warren Buffett's Berkshire Hathaway Inc. (NYSE: BRK) has also increased its stake in UnitedHealth, acquiring 5,039,564 shares during the second quarter. This investment reflects Buffett's strategy to diversify his portfolio, which recently saw a reduction in Apple Inc. (NASDAQ: AAPL) holdings and an exit from T-Mobile US Inc. (NASDAQ: TMUS).

Regulatory Challenges as Opportunities Arise

Nevertheless, UnitedHealth navigates through regulatory challenges as the Department of Justice revisits investigations surrounding its 2022 acquisition of Change Healthcare. The scrutiny particularly focuses on data-sharing practices between UnitedHealth's insurance segment and its Optum services division.

Current Market Trends and Stock Performance

UnitedHealth's stock closed down slightly at $271.49 before experiencing a jump in after-hours trading to $300.50, indicating a $29.01 increase per share. Despite this bounce, the stock remains down by 46.19% year-to-date and has a fluctuating 52-week range between $234.60 and $630.73.

The company's trading metrics reveal a price-to-earnings ratio of 11.76 and a dividend yield of 3.26%, with a market capitalization standing at $245.88 billion and an average trading volume of 16.30 million shares. Despite the temporary surge in stock price, analysts note that the company currently exhibits negative price trends in both short and long-term outlooks.

Frequently Asked Questions

What triggered the recent spike in UnitedHealth's stock price?

The stock surged following the announcement of significant investments by Michael Burry and Warren Buffett, hinting at a potential recovery.

What is Michael Burry's stake in UnitedHealth?

Burry, via Scion Asset Management, holds considerable call contracts on 350,000 shares and a direct investment of $6 million in 20,000 shares.

How has Berkshire Hathaway influenced UnitedHealth's position?

Warren Buffett's Berkshire Hathaway secured a new position comprising over 5 million shares in UnitedHealth, bolstering confidence in the firm's market position.

What are the regulatory challenges facing UnitedHealth?

The Department of Justice is investigating UnitedHealth's data-sharing practices following its 2022 acquisition of Change Healthcare, posing challenges for the company.

How does UnitedHealth's stock compare in terms of performance metrics?

The stock has a price-to-earnings ratio of 11.76, a dividend yield of 3.26%, and remains down significantly year-to-date, highlighting concerns among analysts.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.